Abstract: The present invention relates to piperazine derivatives that act as inhibitors of stearoyl-CoA desaturase. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.
Type:
Grant
Filed:
March 20, 2009
Date of Patent:
October 18, 2011
Assignee:
Forest Laboratories Holdings Limited
Inventors:
Kumar Sundaresan, Sandeep N. Raikar, Srinivasa Raju Sammeta, Ganesh Prabhu, Hosahalli Subramanya, Alexander Bischoff
Abstract: The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.
Abstract: The present invention relates to compounds of formula I, II, III or IV: wherein R1-R4, R7-R10, R13-R17 and R20-R24 are as described herein. The compounds are active as cannabinoid receptor ligands, e.g., CB2 ligands. Methods of preparing the compounds, compositions containing the compounds and methods of treatment using the compounds are also disclosed.
Type:
Grant
Filed:
August 27, 2007
Date of Patent:
July 21, 2009
Assignee:
Forest Laboratories Holding Limited
Inventors:
Gian-Luca Araldi, Matthew Ronsheim, Nhut K. Diep
Abstract: Methods for the synthesis of heterocyclic compounds including N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide and pharmaceutically acceptable salts thereof.
Type:
Grant
Filed:
July 3, 2007
Date of Patent:
March 31, 2009
Assignee:
Forest Laboratories Holdings Limited
Inventors:
Gian-Luca Araldi, Melanie Ronsheim, Nhut Diep, Shao Hong Zhou
Abstract: The present invention relates to pyridoimidazole derivatives that act as cannabinoid receptor ligands, e.g., CB2 ligands. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.